InvestingPro Tips highlight that HealthEquity is expected to grow its net income this year and is trading at a high EBIT and EBITDA valuation multiple. Moreover, analysts have revised their earnings downwards for the upcoming period, which may warrant investor caution. The company's stock is generally characterized by low price volatility and is predicted to remain profitable, as it has been over the last twelve months. Notably, HealthEquity does not pay a dividend, which could influence investment decisions for income-focused shareholders.